Alain L. Fymat, BA, BS, MA, MS, PhD, PhD
Board Vice Chair, Science Director, and Scientific Committee Chair
Society for the Advancement of Science in Africa (SASA)
Founding Chair, President/CEO and Institute Professor
International Institute of Medicine & Science
DR. ALAIN L. FYMAT, Ph.D. is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He is also Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and International Organizing Committee Member of several international scientific conferences. He has lectured extensively in the U.S., Europe, Asia, and Africa. He has published ~ 425 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of 62 medical/scientific Journals. Dr. Fymat is a Board member of several institutions, a member of the New York Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. His current research interests are focused on nanomedicine, precision/personalized medicine, neurodegenerative diseases (including Alzheimer, Parkinson, epilepsy, dementias) with many open literature contributions in these several areas.
Lie at the interface between medicine and science, particularly molecular/personal/precision medicine, nanomedicine, nanobiotechnology, human genetics/epigenetics/ecogenetics, and neurological disorders (particularly Alzheimer, Parkinson, epilepsy, dementia, etc.).
He has received numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He has lectured extensively in several national and international academic, professional, governmental and industrial venues. He is the Editor-in-Chief, Honorable Editor or Editor of 54 medical/scientific Journals to which he contributes regularly. He is a professional member of the New York Academy of Sciences, an advisor to the American Heart/Stroke Association (Coachella Valley Division) and a reviewer for the prestigious UNESCO Newton Prize.
He has extensively published (~ 425 scholarly publications (including patents, books & monographs, book chapters, refereed articles).